High-yield points
- Always look for a lesion: a focal lesion driving LGS can sometimes be resected or ablated with lasting seizure freedom .
- Corpus callosotomy for drop attacks:
- about 70% have ≥50% reduction and about 20% become seizure-free in LGS;
- laser and open approaches perform similarly .
- For atonic seizures, pooled uncontrolled data favor callosotomy over VNS: 86% vs 58% responders .
- CM thalamus is a promising target:
- DBS (ESTEL) reduced electrographic seizures ;
- RNS gave 62% responders in a real-world series .
- Cannabidiol cut drop seizures by a median 44% vs 22% on placebo .
Landmark papers
- GWPCARE4 (Thiele et al., Lancet 2018): randomized, double-blind, placebo-controlled phase 3 trial of cannabidiol 20 mg/kg. Drop seizures fell by a median 43.9% vs 21.8% on placebo .
- ESTEL (Dalic et al., Ann Neurol 2022): randomized, blinded trial of centromedian thalamic DBS in 20 young adults with LGS. Electrographic responders were 59% vs 0%; diary seizures 50% vs 22%, not significant .
Lennox–Gastaut syndrome (LGS) is a severe developmental and epileptic encephalopathy whose seizures are frequently resistant to medication . It is defined by a triad (see caveats):
- multiple seizure types, especially tonic seizures (often in sleep) and atonic or drop seizures;
- slow (under 3 Hz) spike-and-wave on EEG, with generalized paroxysmal fast activity in sleep;
- cognitive impairment.
Most children do not become seizure-free with medication (see caveats). Surgery has three roles :
- curative: removing a focal lesion that drives the generalized network;
- palliative disconnection: corpus callosotomy, mainly for drop attacks;
- neuromodulation: VNS, and centromedian thalamic DBS or RNS.
Evaluate every child for a surgical target
- Look for a lesion first. LGS can be the secondary network effect of a focal lesion, for example:
- focal cortical dysplasia;
- tuberous sclerosis;
- perinatal stroke;
- a vascular lesion.
- Removing it can bring seizure freedom from the "generalized" epilepsy in selected children .
- Boston case series : 5 children, selected because they were seizure-free more than a year after surgery, had electroclinically classic generalized tonic seizures from a single lesion (3 frontal; 3 FCD). After resection or laser ablation, seizure freedom had lasted 1.7–4.4 years. A selected series gives no success rate.
- The authors urge timely surgical evaluation whenever a lesion is presumed, before the secondary network becomes fixed.
- Workup:
- high-resolution MRI;
- PET;
- video-EEG looking for consistent lateralizing features.
- Hemispheric lesions may warrant hemispherotomy (see caveats).
Corpus callosotomy: the main palliative operation
- Who it's for: drop attacks (atonic and tonic falls) that cause injury.
- LGS-specific meta-analysis (48 studies, 822 patients; no randomized trials) :
- ≥50% seizure reduction: 69.6%;
- ≥75% reduction: 38.2%;
- seizure freedom: 20.4%.
- No difference by extent (anterior vs complete) or by approach (open, laser, endoscopic).
- Older age at surgery independently predicted response.
- Laser vs open callosotomy (individual-patient meta-analysis, 948 patients, all epilepsies) :
- similar outcomes:
- seizure freedom 14.5% vs 20.0%;
- drop-attack freedom 51.3% vs 45.1%;
- ≥50% reduction 52.6% vs 55.2%.
- Laser: shorter hospital stay (median 2 vs 6 days), but more subsequent epilepsy surgery (24.4% vs 10.1%).
- Complications: 13.2% with 1–2 laser trajectories vs 54.8% with 3–5.
- LGS was an independent predictor of seizure freedom in adults (OR 3.65).
- Callosotomy vs VNS for atonic seizures (systematic review) :
- ≥50% reduction 85.6% vs 57.6% (RR 1.5);
- VNS side effects were mostly mild (hoarseness 22%);
- callosotomy's commonest complication was disconnection syndrome (13.2%).
- Practical approach (see caveats):
- anterior two-thirds first in children with language or higher function to preserve;
- complete callosotomy in severely impaired children, or as a second stage.
Neuromodulation
- VNS:
- well tolerated;
- a reasonable first device, especially when drop attacks are not dominant (see caveats).
- Centromedian thalamic DBS (ESTEL trial) :
- Who: 20 young adults with LGS; bilateral CM-DBS; randomized and blinded for 3 months.
- Electrographic seizures: 59% vs 0% responders, compared with control.
- Diary seizures: 50% vs 22%, not significant.
- At study exit, median diary-seizure reduction was 46.7%.
- Responsive neurostimulation (RNS) (37 patients, 95% pediatric, four US centers) :
- responder rate (≥50%) 62%; 10% had ≥90% reduction;
- thalamic CM-only stimulation was the commonest configuration (76%), and 83% of responders had it;
- infections led to explantation in 4.
- The case for thalamic targets: the CM thalamus is thought to be a hub of the LGS network (see caveats), making it a promising target .
Medical therapy (for context)
- Cannabidiol 20 mg/kg (GWPCARE4) :
- drop seizures fell by a median 43.9% vs 21.8% on placebo;
- adverse events in 86%, mostly mild or moderate.
- Also used: fenfluramine, rufinamide, clobazam, and the ketogenic diet (see caveats).
Related topics
- Corpus Callosotomy: the main palliative operation.
- DBS for Epilepsy: centromedian stimulation.
- Responsive Neurostimulation: thalamic RNS.
- Hemispherectomy: hemispheric lesions.
- Epilepsy Surgery Overview: surgical context.
- Corpus Callosotomy: Procedure: step-by-step procedure.
- Vagus Nerve Stimulator Implantation: step-by-step procedure.
- Thalamic Deep Brain Stimulation for Epilepsy: Procedure: step-by-step procedure.
- Responsive Neurostimulation (RNS) Placement: step-by-step procedure.
References
- Thiele EA, Marsh ED, French JA, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2018;391(10125):1085–1096. doi:10.1016/S0140-6736(18)30136-330136-3). PMID 29395273. verified
- Hagen CW, Keator CG. Surgical management of Lennox-Gastaut syndrome: a focused update on resective surgery and corpus callosotomy. Semin Pediatr Neurol 2025;56:101235. doi:10.1016/j.spen.2025.101235. PMID 41371869. verified
- Kampman SL, Latzer IT, Warren AEL, et al. Resolution of generalized tonic seizures following focal ablative or resective surgery. Epileptic Disord 2026;28(2):333–343. doi:10.1002/epd2.70148. PMID 41553726. verified
- Samanta D, Ramani PK, Abel TJ, et al. Corpus callosotomy in Lennox-Gastaut syndrome: effectiveness, safety, and predictors of outcome: a systematic review and meta-analysis. Epilepsy Res 2026;227:107902. doi:10.1016/j.eplepsyres.2026.107902. PMID 42664727. verified
- Merenzon MA, O'Malley G, Terry F, et al. Stereotactic laser ablation vs open corpus callosotomy: a systematic review and meta-analysis of individual patient data. Oper Neurosurg 2026;30(5):641–652. doi:10.1227/ons.0000000000001709. PMID 40719433. verified
- Rolston JD, Englot DJ, Wang DD, et al. Corpus callosotomy versus vagus nerve stimulation for atonic seizures and drop attacks: a systematic review. Epilepsy Behav 2015;51:13–17. doi:10.1016/j.yebeh.2015.06.001. PMID 26247311. verified
- Dalic LJ, Warren AEL, Bulluss KJ, et al. DBS of thalamic centromedian nucleus for Lennox-Gastaut syndrome (ESTEL trial). Ann Neurol 2022;91(2):253–267. doi:10.1002/ana.26280. PMID 34877694. verified
- Swartwood SM, Bollo RJ, Chu CJ, et al. Real-world outcomes of responsive neurostimulation in patients with Lennox-Gastaut syndrome: a multicenter retrospective study. Epilepsia Open 2026;11(4):1244–1254. doi:10.1002/epi4.70283. PMID 42138251. verified
Verification (2026-11-17):
- Each reference's authors, title, journal, year, volume, pages, DOI and PMID were checked on PubMed. Numbers were checked against the PubMed abstracts.
Caveats:
- The following are standard teaching, not drawn from the cited abstracts:
- that most children are not made seizure-free by medication;
- VNS as a reasonable first device;
- the CM thalamus as a network hub;
- the diagnostic triad details (generalized paroxysmal fast activity, nocturnal tonic seizures);
- the list of underlying lesions;
- the workup;
- hemispherotomy for hemispheric lesions;
- the anterior-first callosotomy strategy;
- other medicines (fenfluramine, rufinamide, clobazam, diet).
- Reference 1's eligibility criteria (slow spike-and-wave, more than one generalized seizure type) support the EEG and seizure-type elements.
- Reference 5 includes all epilepsies and adults.
- Reference 7 enrolled young adults.
- All surgical data are observational except ESTEL.
- The figure is an original schematic.